Literature DB >> 10465786

The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival.

H J Okano1, W Y Park, J P Corradi, R B Darnell.   

Abstract

Paraneoplastic cerebellar degeneration (PCD) is a disorder in which breast or ovarian tumors express an onconeural antigen termed cdr2, which normally is expressed in cerebellar Purkinje neurons. This leads to an immune response to cdr2 that is associated with tumor immunity and autoimmune cerebellar degeneration. We have found that cdr2, a cytoplasmic protein harboring a helix-leucine zipper (HLZ) motif, interacts specifically with the HLZ motif of c-Myc. Both proteins colocalize in the cytoplasm of adult cerebellar Purkinje neurons, and coimmunoprecipitate from tumor cell lines and cerebellar extracts. cdr2 down-regulates c-Myc-dependent transcription in cotransfection assays, and redistributes Myc protein in the cytoplasm. Disease antisera from six of six PCD patients specifically blocked the interaction between cdr2 and c-Myc in vitro. These data indicate that cdr2 normally sequesters c-Myc in the neuronal cytoplasm, thereby down-regulating c-Myc activity, and suggest a mechanism whereby inhibition of cdr2 function by autoantibodies in PCD may contribute to Purkinje neuronal death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465786      PMCID: PMC316965          DOI: 10.1101/gad.13.16.2087

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  60 in total

1.  Changes in immediate early gene expression during postnatal development of cat cortex and cerebellum.

Authors:  M A McCormack; K M Rosen; L Villa-Komaroff; G D Mower
Journal:  Brain Res Mol Brain Res       Date:  1992-01

2.  Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration.

Authors:  K Sakai; D J Mitchell; T Tsukamoto; L Steinman
Journal:  Ann Neurol       Date:  1990-11       Impact factor: 10.422

3.  A new physiological concept on cerebellum.

Authors:  M Ito
Journal:  Rev Neurol (Paris)       Date:  1990       Impact factor: 2.607

4.  Myc and Max associate in vivo.

Authors:  E M Blackwood; B Lüscher; R N Eisenman
Journal:  Genes Dev       Date:  1992-01       Impact factor: 11.361

5.  Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes.

Authors:  H F Furneaux; L Reich; J B Posner
Journal:  Neurology       Date:  1990-07       Impact factor: 9.910

6.  Intraneuronal IgG in the central nervous system: uptake by retrograde axonal transport.

Authors:  R H Fabian; G Petroff
Journal:  Neurology       Date:  1987-11       Impact factor: 9.910

7.  Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration.

Authors:  H Fathallah-Shaykh; S Wolf; E Wong; J B Posner; H M Furneaux
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

8.  Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro.

Authors:  A Groyer; G Schweizer-Groyer; F Cadepond; M Mariller; E E Baulieu
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

9.  Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model.

Authors:  F Graus; I Illa; M Agusti; T Ribalta; F Cruz-Sanchez; C Juarez
Journal:  J Neurol Sci       Date:  1991-11       Impact factor: 3.181

10.  Immunolocalization of c-myc oncoprotein in mucinous and serous adenocarcinomas of the ovary.

Authors:  H Sasano; H Nagura; S G Silverberg
Journal:  Hum Pathol       Date:  1992-05       Impact factor: 3.466

View more
  34 in total

1.  MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network.

Authors:  A N Billin; A L Eilers; K L Coulter; J S Logan; D E Ayer
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing.

Authors:  A D Polydorides; H J Okano; Y Y Yang; G Stefani; R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  MYC leads the way.

Authors:  Niranjan Venkateswaran; Maralice Conacci-Sorrell
Journal:  Small GTPases       Date:  2017-11-25

Review 4.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

5.  Heterogeneous stock rats: a model to study the genetics of despair-like behavior in adolescence.

Authors:  K Holl; H He; M Wedemeyer; L Clopton; S Wert; J K Meckes; R Cheng; A Kastner; A A Palmer; E E Redei; L C Solberg Woods
Journal:  Genes Brain Behav       Date:  2017-09-26       Impact factor: 3.449

6.  Post-translational control of Myc function during differentiation.

Authors:  Maralice Conacci-Sorrell; Robert N Eisenman
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

7.  c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice.

Authors:  Ganesh Rao; Carolyn A Pedone; Cheryl M Coffin; Eric C Holland; Daniel W Fults
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

8.  The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells.

Authors:  Kevin J O'Donovan; Jennifer Diedler; Graeme C Couture; John J Fak; Robert B Darnell
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

9.  Centrocortin cooperates with centrosomin to organize Drosophila embryonic cleavage furrows.

Authors:  Ling-Rong Kao; Timothy L Megraw
Journal:  Curr Biol       Date:  2009-05-07       Impact factor: 10.834

Review 10.  Enteric autoantibodies and gut motility disorders.

Authors:  Purna Kashyap; Gianrico Farrugia
Journal:  Gastroenterol Clin North Am       Date:  2008-06       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.